Literature DB >> 15019370

Risk factors for central serous chorioretinopathy: a case-control study.

Robert Haimovici1, Sean Koh, David R Gagnon, Todd Lehrfeld, Sarah Wellik.   

Abstract

PURPOSE: To identify systemic factors associated with the development of central serous chorioretinopathy (CSCR).
DESIGN: Retrospective, case-control study. PARTICIPANTS AND CONTROLS: 312 cases and 312 controls.
RESULTS: By use of a multivariate analysis, the previously described risk factors, systemic steroid use (odds ratio [OR], 37.1; 95% confidence interval [CI], 6.2-221.8), and pregnancy (OR, 7.1; 95% CI, 1.0-50.7), were strongly associated with CSCR. Additional risk factors identified by this study include antibiotic use (OR, 6.2; 95% CI, 1.0-37.9), alcohol use (OR, 4.9; 95% CI, 1.5-16.3), untreated hypertension (OR, 3.3; 95% CI, 1.3-8.5), and allergic respiratory disease (OR, 2.5; 95% CI, 1.2-5.1).
CONCLUSIONS: A wide variety of systemic factors are associated with CSCR. Prospective studies are warranted to evaluate the nature and significance of these associations further.

Entities:  

Mesh:

Year:  2004        PMID: 15019370     DOI: 10.1016/j.ophtha.2003.09.024

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  127 in total

1.  Application of multivariate probabilistic (Bayesian) networks to substance use disorder risk stratification and cost estimation.

Authors:  Lawrence Weinstein; Todd A Radano; Timothy Jack; Philip Kalina; John S Eberhardt
Journal:  Perspect Health Inf Manag       Date:  2009-09-16

2.  Evaluation of Choroidal Thickness and Volume during the Third Trimester of Pregnancy using Enhanced Depth Imaging Optical Coherence Tomography: A Pilot Study.

Authors:  Renata T Rothwell; Dália M Meira; Marisa A Oliveira; Lígia F Ribeiro; Sofia L Fonseca
Journal:  J Clin Diagn Res       Date:  2015-08-01

3.  Hypercortisolism induced atypical central serous chorioretinopathy in pregnancy.

Authors:  Tarun Choudhary; Sushil Chawla; Rahul Ray; Savio Pereira
Journal:  Med J Armed Forces India       Date:  2013-04-18

4.  Effect of a topical nonsteroidal anti-inflammatory agent (0.1 % pranoprofen) on acute central serous chorioretinopathy.

Authors:  Seoung Hyun An; Yoon Hyung Kwon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-09       Impact factor: 3.117

5.  Choroidal thickness in pregnant women measured by enhanced depth imaging optical coherence tomography.

Authors:  Junichi Takahashi; Masanori Kado; Keiko Mizumoto; Sho Igarashi; Tsunemaro Kojo
Journal:  Jpn J Ophthalmol       Date:  2013-07-18       Impact factor: 2.447

6.  En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.

Authors:  Daniela Ferrara; Kathrin J Mohler; Nadia Waheed; Mehreen Adhi; Jonathan J Liu; Ireneusz Grulkowski; Martin F Kraus; Caroline Baumal; Joachim Hornegger; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

7.  Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy.

Authors:  Francesco Pichi; Paola Carrai; Antonio Ciardella; Francine Behar-Cohen; Paolo Nucci
Journal:  Int Ophthalmol       Date:  2016-10-18       Impact factor: 2.031

8.  Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association Study.

Authors:  Rosa L Schellevis; Elon H C van Dijk; Myrte B Breukink; Lebriz Altay; Bjorn Bakker; Bobby P C Koeleman; Lambertus A Kiemeney; Dorine W Swinkels; Jan E E Keunen; Sascha Fauser; Carel B Hoyng; Anneke I den Hollander; Camiel J F Boon; Eiko K de Jong
Journal:  JAMA Ophthalmol       Date:  2018-10-01       Impact factor: 7.389

Review 9.  Retinal Diseases that Can Masquerade as Neurological Causes of Vision Loss.

Authors:  Tanyatuth Padungkiatsagul; Loh-Shan Leung; Heather E Moss
Journal:  Curr Neurol Neurosci Rep       Date:  2020-09-15       Impact factor: 5.081

10.  Central serous chorioretinopathy due to tadalafil use.

Authors:  Fatih Mehmet Türkcü; Harun Yüksel; Alparslan Şahin; Mehmet Murat; Yaşar Bozkurt; Ihsan Çaça
Journal:  Int Ophthalmol       Date:  2012-10-14       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.